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OBJECTIVE — To evaluate the brain’s responses to painful visceral and somatic stimuli in
diabetic patients with gastrointestinal symptoms.
RESEARCH DESIGN AND METHODS — The sensitivity to electrical esophageal and
median nerve stimulations was assessed in 15 healthy volunteers and 14 type 1 diabetic patients
with autonomic neuropathy and gastrointestinal symptoms using a euglycemic-
hyperinsulinemic clamp. Evoked brain potentials were recorded.
RESULTS — Patients had reduced sensitivity to esophageal (48%; P  0.001) and median
nerve (80%; P  0.001) stimulations. They also had increased (8.8%; P  0.007) and nonre-
producible (P  0.006) latencies of evoked potentials in response to esophageal stimulations,
with 26% reduction in amplitude (P  0.011). No potential differences were seen to median
nerve stimulations. In diabetic patients, the topographic location of the ﬁrst peak in potentials
was more central (P  0.001) and gastrointestinal symptoms correlated with characteristics of
brain potentials (P  0.049).
CONCLUSIONS — Thisstudysupportsthatdiabetesinduceschangesinperipheralvisceral
nerves as well as in the central nervous system.
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G
astrointestinal symptoms are more
prevalent in diabetic individuals
than in the general population
(1,2). The pathogenesis is undoubtedly
multifactorial, including motor dysfunc-
tion, glycemic control, psychological fac-
tors, etc. (3,4). However, diabetic
autonomic neuropathy (DAN) seems to
play a central role (1,3,5). The aim of this
study, in healthy control subjects and pa-
tients with long-standing diabetes and
gastrointestinal symptoms, was to de-
scribe the following: 1) the sensory
thresholds for electrical esophageal and
median nerve stimulation and 2) the
evoked brain potentials (EPs) recorded
with a high-resolution electroencephalo-
gram system.
RESEARCH DESIGN AND
METHODS— Fourteen type 1 dia-
beticpatients(12female;meanage34.4
years [range 20–51]) and 15 healthy
control subjects (10 female; mean age
33.5 years [21–50]) participated. Pri-
mary gastrointestinal and other diseases
were ruled out with endoscopy where
appropriate. The patients’ diabetes
lasted14–40years(mean22years)and
was managed with multiple insulin in-
jection regimens or insulin pumps.
Mean A1C level was 9.6% (range 7.1–
14.1). DAN was veriﬁed by abnormal
gastric emptying breath tests, heart rate
variability (HRV), and modiﬁed Ewing
tests (6,7). An HRV index was calcu-
lated based on the mean of R-R inter-
vals, the SD of all normal-to-normal
(NN) R-R intervals, the mean of the SDs
of all NN intervals, the SD of sequential
5-min R-R interval means, and the
square root of the mean of the sum of
the squares of differences between adja-
cent NN intervals (6). An autonomic
score was calculated as the sum of or-
thostatic blood pressure changes, R-R
variability upon deep respiration, and
corrected QT (7). All patients had one
or more gastrointestinal symptoms, and
a gastrointestinal symptom score was
calculated based on the sum of the fol-
lowing symptom scores: nausea, vomit-
ing, early satiety, bloating, abdominal
pain, diarrhea, and constipation, all
ranging from no (0) to moderate (1) to
severe (2) symptoms. No medication
(except insulin) was allowed 24 h be-
fore the study.
After 6 h fasting, the blood glucose
level was adjusted in all subjects to 6
mmol/l using a hyperinsulinemic-
hyperglycemic clamp technique (8). A
64 surface electrode electroencephalo-
gram cap was mounted (according to
the international 10–20 system of elec-
trode placement). A 3-mm catheter was
swallowed with the ring electrodes po-
sitionedinthedistalesophagus.Electri-
cal stimulations were applied as single
stimuliconsistingofaseriesofﬁveshort
1-ms square pulses at 200 Hz. The sen-
sations were rated on a 0–10 visual an-
alog scale (VAS): 0, no perception; 3,
vague perception of moderate sensa-
tion; and 5, pain detection threshold.
Afterward, right median nerve stimula-
tion was performed with identical pro-
tocol settings. The electrocardiogram
was monitored during all stimulations.
Fifty identical esophageal and 30
mediannervestimulationswereapplied
twice at 0.2 Hz with 5-min breaks. The
electroencephalogram signals were re-
cordedwithasamplingrateof1,000Hz
(SynAmps; Neuroscan, El Paso, TX).
The EPs were processed ofﬂine, and the
mean of the two stimulation runs was
computed (version 4.3.1; Neuroscan)
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1274 DIABETES CARE, VOLUME 32, NUMBER 7, JULY 2009Figure1—A:EPsatvertex(Cz)inresponsetopainfulesophagealelectricalstimulation.Thegrandmean(leftpanel)andtypicalexamples(rightpanel)
are illustrated for both healthy control subjects (top panel) and diabetic patients (bottom panel) with veriﬁed autonomic neuropathy and related
gastrointestinalsymptoms.Thelatencies(B)andamplitudes(C)oftheEPsatCzareillustrated.Includingtheﬁrstfourcomponents(N1–P2),thelatencies
were increased and the amplitudes reduced in the diabetic patients. Error bars indicate SE of the mean. *Signiﬁcant results of the post hoc test.
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cation of each component was identi-
ﬁed on topographic maps. The latencies
and amplitudes of each component
(N1-P1-N2-P2-N3) at Cz (vertex) were
identiﬁed blindly using topographic
brain maps as guidance. For correlation
analysis, a total electroencephalogram
index was calculated based on the aver-
age of the N1, P1, and N2 latencies
(mean 100) divided by the average of
the N1, P1, and N2 amplitudes (mean
100).
RESULTS— The blood glucose level
was adjusted to a mean of 6.0  0.1
mmol/l for the control subjects and 6.2 
0.2 mmol/l for the patients. With all three
sensory levels combined, the diabetic pa-
tients had reduced sensitivity to esopha-
geal (F  16, P  0.001; post hoc VAS 1,
P  0.03; VAS 3, P  0.01; and VAS 5,
P0.03)andmediannerve(F26,P
0.001; post hoc VAS 1, P  0.15; VAS 3,
P  0.048; and VAS 5, P  0.001) stim-
ulation. There were no signiﬁcant corre-
lations between esophageal and median
nerve thresholds in either group (all P 
0.3).
When the two stimulation runs for
EPs in control subjects were compared,
they were reproducible (latencies: F 
3.3, P  0.11; amplitudes: F  0.3, P 
0.62). The EPs were more variable in
the diabetic patients, with longer laten-
cies in the second run (F  11, P 
0.006).
When the two stimulation runs
were combined and analyzed (N1-P1-
N2-P2), we found that the patients had
increasedlatencies(F  7.6;P  0.007)
and reduced amplitudes (F  6.7; P 
0.01) of the EPs (Fig. 1B and C). For
median nerve stimulation, neither the
latencies (F  0.7; P  0.4) nor the
amplitudes (F  0.5; P  0.5) were dif-
ferent from those of the healthy control
subjects. The location of the ﬁrst posi-
tive deﬂection of the EP in patients was
shifted more centrally compared with
the frontal location in the healthy con-
trol subjects (
2  17; P  0.001),
whereas no differences in the topo-
graphic distribution of the other peaks
were found (all P  0.5).
The gastrointestinal symptom score
only correlated with the total electroen-
cephalogram index (r  0.55; P 
0.049);increasinglyabnormalesophageal
EP correlated positively with the symp-
tom. The total electroencephalogram in-
dex did not correlate with the diabetes
duration (P  0.3), A1C level (P  0.6),
HRV index (P  0.8), or autonomic score
(P  0.5).
CONCLUSIONS— Diabetic patients
had reduced esophageal sensitivity, with
reducedqualityandnonreproducibleEPs
having increased latencies and reduced
amplitudes. The electroencephalogram
ﬁndings correlated with the gastrointesti-
nal symptoms.
Our results are comparable with
previous ﬁndings in small samples of
patients (9–11). The observed decrease
in sensation and increase in latencies of
EPs indicate altered sensory processing.
DAN induces a decrease in conduction
velocity of both peripheral and spinal
nerve ﬁbers, contributing to an increase
in latency (10). However, the visceral
sensory system is not hardwired, and
neuroplastic changes could be expected
in diabetic individuals involving spinal
and supraspinal reorganization with ac-
tivation of latent ascending pathways as
well as descending inhibitory or facili-
tatorycontrolmechanisms(12).Acom-
bination of all these mechanisms is
probably involved, resulting in the ﬁnal
conﬁguration of the EPs. Structural ce-
rebral changes could also explain the
ﬁndings. Reduced density of cortical
gray matter, cortical atrophy, and deep-
white-matterlesionsareseeninpatients
with long-lasting diabetes (13). Aging
has shown to increase sensory thresh-
olds, reduce amplitude, and increase la-
tencies of somatic EPs (14). Similar
aging-like changes may be present in
long-lasting diabetes.
The reduced upper gastrointestinal
sensitivity with altered and delayed
brain responses seems somehow sur-
prising given that diabetic patients have
an increased prevalence of gastrointes-
tinal symptoms (1,2). However, the to-
pographic ﬁndings indicate changes in
the primary pain processing of visceral
pain, and such central changes may re-
sultingastrointestinaleventsbeingper-
ceived in an abnormal way (15). This
theory is supported by gastrointestinal
symptoms being correlated with the de-
gree of abnormal EPs. Hence, viscero-
sensory EPs may be useful biomarkers
of diabetes-induced neuropathic-like
mechanisms, which are not assessed us-
ing traditional cardiovascular tests.
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